New OCSC BioTech Startup Company Member: Anviron

Anviron develops drug therapeutics for the treatment of solid tumor cancers. Their launch candidate, ANV221, was awarded Orphan Drug Designation for the treatment of Pancreatic Cancer.
Anvirons co-founding university research institutions include the University of California, San Diego and the University of Tennessee Health Science Center.
OC Startups DirectoryCategory:
(Get a listing for your company or organization in the OCSC Startups Ecosystem Directory here.)